Eyeon Group Valuation
Is EOID undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EOID when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate EOID's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate EOID's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EOID?
Other financial metrics that can be useful for relative valuation.
| What is EOID's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 24.7x |
| Enterprise Value/EBITDA | -56.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does EOID's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.7x | ||
MSAB B Micro Systemation | 2.4x | 10.6% | SEK 978.8m |
ADVE Advenica | 2.9x | 9.0% | SEK 459.7m |
CLAV Clavister Holding AB (publ.) | 2.4x | 14.9% | SEK 424.1m |
PREC Precise Biometrics | 3x | 16.5% | SEK 237.9m |
EOID Eyeon Group | 27.2x | n/a | SEK 528.4m |
Price-To-Sales vs Peers: EOID is expensive based on its Price-To-Sales Ratio (27.2x) compared to the peer average (2.7x).
Price to Earnings Ratio vs Industry
How does EOID's PE Ratio compare vs other companies in the SE Software Industry?
Price-To-Sales vs Industry: EOID is expensive based on its Price-To-Sales Ratio (27.2x) compared to the Swedish Software industry average (2.4x).
Price to Sales Ratio vs Fair Ratio
What is EOID's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 27.2x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate EOID's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.